Journey Medical Corporation
General ticker "DERM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $140.3M (TTM average)
Journey Medical Corporation follows the US Stock Market performance with the rate: 36.6%.
Estimated limits based on current volatility of 3.1%: low 7.48$, high 7.96$
Factors to consider:
- Total employees count: 58 (-27.5%) as of 2023
- Top business risk factors: Liquidity and credit risks, Economic downturns and volatility, Regulatory and compliance, Market competition, Operational and conduct risks
- Current price 24.6% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.91$, 6.27$]
- 2025-12-31 to 2026-12-31 estimated range: [2.30$, 5.07$]
Financial Metrics affecting the DERM estimates:
- Positive: with PPE of -5.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -10.18 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 25.01 <= 41.86
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Positive: Interest expense per share per price, % of 3.01 <= 3.41
- Negative: negative Industry operating cash flow (median)
Short-term DERM quotes
Long-term DERM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $73.67MM | $79.18MM | $56.13MM |
| Operating Expenses | $101.19MM | $81.25MM | $69.81MM |
| Operating Income | $-27.52MM | $-2.07MM | $-13.68MM |
| Non-Operating Income | $-2.05MM | $-1.56MM | $-0.93MM |
| Interest Expense | $2.02MM | $1.70MM | $2.70MM |
| R&D Expense | $10.94MM | $7.54MM | $9.86MM |
| Income(Loss) | $-29.57MM | $-3.63MM | $-14.61MM |
| Taxes | $0.06MM | $0.22MM | $0.06MM |
| Profit(Loss)* | $-29.63MM | $-3.85MM | $-14.67MM |
| Stockholders Equity | $16.98MM | $20.35MM | $20.07MM |
| Inventory | $14.16MM | $10.21MM | $14.43MM |
| Assets | $105.16MM | $76.85MM | $80.24MM |
| Operating Cash Flow | $-13.53MM | $5.24MM | $-9.13MM |
| Capital expenditure | $20.00MM | $5.00MM | $15.00MM |
| Investing Cash Flow | $-20.00MM | $-5.00MM | $-15.00MM |
| Financing Cash Flow | $16.46MM | $-4.80MM | $16.99MM |
| Earnings Per Share** | $-1.69 | $-0.21 | $-0.72 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.